Zhaoke Ophthalmology Limited (HKG:6622)

Zhaoke Ophthalmology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	31.97	69.32	18.75	-	-
Revenue Growth (YoY)	-53.88%	269.73%	-	-	-
Cost of Revenue	15.92	17.53	4.5	-	-
Gross Profit	16.05	51.8	14.25	-	-
Selling, General & Admin	117.92	134.28	136.29	116.06	178.82
Research & Development	171.62	203.7	333.05	296.43	220.06
Other Operating Expenses	1.83	12.94	-1.26	-0.15	-0.01
Operating Expenses	291.38	350.92	468.09	412.34	398.87
Operating Income	-275.33	-299.12	-453.84	-412.34	-398.87
Interest Expense	-9.08	-9.5	-7.92	-3.14	-1.95
Interest & Investment Income	44.37	75.23	77.4	30.42	5.04
Currency Exchange Gain (Loss)	30.77	-4.71	-3.65	-29.73	13.41
Other Non Operating Income (Expenses)	-	-	-	-	-1,763
EBT Excluding Unusual Items	-209.27	-238.11	-388.01	-414.8	-2,146
Asset Writedown	-	-10.81	-	-	-
Other Unusual Items	0.29	11.42	3.52	7.48	16.09
Pretax Income	-208.98	-237.49	-384.49	-407.32	-2,130
Income Tax Expense	-	-	0.55	-	-
Net Income	-208.98	-237.49	-385.04	-407.32	-2,130
Net Income to Common	-208.98	-237.49	-385.04	-407.32	-2,130
Shares Outstanding (Basic)	547	546	544	542	412
Shares Outstanding (Diluted)	547	546	544	542	412
Shares Change (YoY)	0.15%	0.41%	0.32%	31.47%	173.12%
EPS (Basic)	-0.38	-0.43	-0.71	-0.75	-5.16
EPS (Diluted)	-0.38	-0.43	-0.71	-0.75	-5.16
Free Cash Flow	-	-263.82	-360.13	-409.7	-310.67
Free Cash Flow Per Share	-	-0.48	-0.66	-0.76	-0.75
Gross Margin	50.21%	74.72%	75.98%	-	-
Operating Margin	-861.09%	-431.49%	-2420.47%	-	-
Profit Margin	-653.60%	-342.58%	-2053.54%	-	-
Free Cash Flow Margin	-	-380.56%	-1920.70%	-	-
EBITDA	-239.42	-263.22	-420.16	-384.55	-377.53
D&A For EBITDA	35.91	35.91	33.68	27.78	21.34
EBIT	-275.33	-299.12	-453.84	-412.34	-398.87

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.